Covid-19 | Subscribe

Guideline For Electronic Submission of Clinical Trial Documents (Amendments, Bioequivalence Studies, Responses, Notifications, And Serious Adverse Events)

Home > Guideline For Electronic Submission of Clinical Trial Documents (Amendments, Bioequivalence Studies, Responses, Notifications, And Serious Adverse Events)

26 Jan Guideline For Electronic Submission of Clinical Trial Documents (Amendments, Bioequivalence Studies, Responses, Notifications, And Serious Adverse Events)

Posted at 14:02h in by

This guideline serves as a guide to applicants on the electronic submission process for major activities performed within Clinical Trials Unit (CTU).

Download latest version

Download archived version
Document Number: SAHPGL-CEM-CT-01
Version: 3
Date Updated: 05/09/2022
File Type: pdf
Category: Communication to industry, Guideline
Unit: Clinical Trials